The CAIX and CAXII inhibitors ureido-sulfonamide and glycosyl coumarin have been shown to inhibit primary tumor growth and to limit the colonization of metastatic tumor cells in the lung in a 4T1 breast cancer in vivo model [30]–[32]. This evidence concerns the gene CA9 and breast cancer.